ACTRN12614001112651已完成4 期
Effect of spironolactone on brown fat activity in healthy adult humans
Professor Ken Ho0 个研究点目标入组 10 人开始时间: 2014年10月20日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •healthy adults aged 18-50 years old, BMI<35
排除标准
- 未提供
研究者
相似试验
尚未招募
不适用
Effect of spironolactone on human brown fat in patients with primary aldosteronismPrimary aldosteronismDiet and Nutrition - ObesityMetabolic and Endocrine - Other metabolic disordersObesityACTRN12614001116617Professor Ken Ho12
尚未招募
不适用
Effect of Mineralocorticoid on Brown Fat in Humans with Primary Aldosteronism who will be treated with SurgeryPrimary aldosteronismDiet and Nutrition - ObesityMetabolic and Endocrine - Other metabolic disordersObesityACTRN12614001129673Professor Ken Ho12
已完成
4 期
Evaluation of effect of spironolactone on proteinuria in kidney transplant patientsIRCT20230516058205N1Esfahan University of Medical Sciences60
已完成
2 期
The effect of spironolactone in treatment of heart failureHeart Failure.Congestive heart failureIRCT2015101924597N1Vice chancellor for research of Iran university of medical sciences60
已完成
4 期
The effect of the low-dose spironolactone in post adolescent acne: a randomized, double-blind, placebo-controlled trial.acne vulgaris in women who age from 25ᇁ years oldspironolactonepostadolescent acneTCTR20190417004Faculty of Medicine, Chulalongkorn University62